A Study Of Triphaladya Churna In The Treatment Of Urine Retention In Benign Prostatic Hyperplasia
Phase 2
- Conditions
- Health Condition 1: N394- Other specified urinary incontinence
- Registration Number
- CTRI/2023/02/049992
- Lead Sponsor
- SHUBHAM SHARMA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
A) K/C/O Vatashthila.
B) Patient having any of 3 sign & symptoms of disease like incomplete emptying, frequency, intermittency,urgency,weak stream, straining and nocturia.
C) Male patient, irrespective of socio- economic status.
Exclusion Criteria
a) Bladder neck stenosis, bladder diverticulum, neurogenic bladder, neoplasm of bladder, urethral stricture.
b) Patients with malignancy of prostate
c) Patient with associated disease like T.B. , Leprosy, Venereal disease ,immuno- compromised.
d) Patient with major complication like uremia , septicemia , shock, renal failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe the efficacy of Triphaladya churna in the management of urine retention in Vatashthila (Benign Prostatic Hyperplasia)Timepoint: Triphaladya churna oral administration 1 karsha with lukewarm water twice a day for 15 days. <br/ ><br>Follow-up will be on 7th and 15th day. <br/ ><br>Total duration of study will be 15 days.
- Secondary Outcome Measures
Name Time Method 1) To provide safe and cost effective treatment <br/ ><br>for relieving urine retention in benign prostatic hyperplasia. <br/ ><br>2) To observe the adverse effects of Triphaladya churna.Timepoint: Follow-ups will be on 7th and 15th day. <br/ ><br>Total duration of study will be 15 days.